APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +24.1% | +33.3% | +58.3% | +172.4% | +92.8% | +1.8% | +0.0% | +0.5% | +0.2% | – | |
| – | +46.9% | +89.3% | +36.1% | +2.5% | +30.3% | +46.2% | +2.0% | +4.7% | +0.4% | +43.8% | -2.9% | – | |
| – | – | -152.1% | – | +141.6% | -259.9% | – | – | – | – | – | -668.6% | – | |
| – | – | +110.2% | -85.5% | +1,372.5% | -99.9% | +431,600.0% | -82.2% | -100.0% | – | -100.0% | – | – | |
| – | +16.9% | -81.1% | +187.4% | -1.6% | – | -72.0% | +501.8% | -77.0% | -1,708.4% | -87.8% | +980.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.1% | – | -100.0% | – | +11,481.2% | -98.6% | +89.7% | +1,572.7% | +1,799.6% | +9.7% | -74.0% | – | |
| – | -210.7% | – | -148.5% | – | – | -251.6% | – | -195.9% | – | +1,255.0% | -208.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.